152 related articles for article (PubMed ID: 37658673)
21. Receptor-mediated therapeutic transport across the blood-brain barrier.
Wang YY; Lui PC; Li JY
Immunotherapy; 2009 Nov; 1(6):983-93. PubMed ID: 20635914
[TBL] [Abstract][Full Text] [Related]
22. Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology.
Moura RP; Martins C; Pinto S; Sousa F; Sarmento B
Expert Opin Drug Deliv; 2019 Mar; 16(3):271-285. PubMed ID: 30767695
[TBL] [Abstract][Full Text] [Related]
23. Characterization of basigin monoclonal antibodies for receptor-mediated drug delivery to the brain.
Christensen SC; Krogh BO; Jensen A; Andersen CBF; Christensen S; Nielsen MS
Sci Rep; 2020 Sep; 10(1):14582. PubMed ID: 32884039
[TBL] [Abstract][Full Text] [Related]
24. Application of the Phage Display Technology for the Development of Peptide- mediated Drug Delivery Systems through the Blood-Brain Barrier.
Suárez VM; Vispo NS; Ramos OS
Curr Pharm Biotechnol; 2021; 22(11):1394-1403. PubMed ID: 33397231
[TBL] [Abstract][Full Text] [Related]
25. Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core.
Clark AJ; Davis ME
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12486-91. PubMed ID: 26392563
[TBL] [Abstract][Full Text] [Related]
26. A Perfused In Vitro Human iPSC-Derived Blood-Brain Barrier Faithfully Mimics Transferrin Receptor-Mediated Transcytosis of Therapeutic Antibodies.
Burgio F; Gaiser C; Brady K; Gatta V; Class R; Schrage R; Suter-Dick L
Cell Mol Neurobiol; 2023 Nov; 43(8):4173-4187. PubMed ID: 37698826
[TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood-brain barrier.
Kratzer I; Wernig K; Panzenboeck U; Bernhart E; Reicher H; Wronski R; Windisch M; Hammer A; Malle E; Zimmer A; Sattler W
J Control Release; 2007 Feb; 117(3):301-11. PubMed ID: 17239472
[TBL] [Abstract][Full Text] [Related]
28. Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood-brain barrier in vitro is dependent on its binding affinity.
Haqqani AS; Thom G; Burrell M; Delaney CE; Brunette E; Baumann E; Sodja C; Jezierski A; Webster C; Stanimirovic DB
J Neurochem; 2018 Sep; 146(6):735-752. PubMed ID: 29877588
[TBL] [Abstract][Full Text] [Related]
29. Transcellular brain drug delivery: A review on recent advancements.
Azarmi M; Maleki H; Nikkam N; Malekinejad H
Int J Pharm; 2020 Aug; 586():119582. PubMed ID: 32599130
[TBL] [Abstract][Full Text] [Related]
30. A filter-free blood-brain barrier model to quantitatively study transendothelial delivery of nanoparticles by fluorescence spectroscopy.
De Jong E; Williams DS; Abdelmohsen LKEA; Van Hest JCM; Zuhorn IS
J Control Release; 2018 Nov; 289():14-22. PubMed ID: 30243824
[TBL] [Abstract][Full Text] [Related]
31. Sorting Tubules Regulate Blood-Brain Barrier Transcytosis.
Villaseñor R; Schilling M; Sundaresan J; Lutz Y; Collin L
Cell Rep; 2017 Dec; 21(11):3256-3270. PubMed ID: 29241551
[TBL] [Abstract][Full Text] [Related]
32. Two peptides targeting endothelial receptors are internalized into murine brain endothelial cells.
Hudecz D; Sigurdardóttir SB; Christensen SC; Hempel C; Urquhart AJ; Andresen TL; Nielsen MS
PLoS One; 2021; 16(4):e0249686. PubMed ID: 33798235
[TBL] [Abstract][Full Text] [Related]
33. Transthyretin as a new transporter of nanoparticles for receptor-mediated transcytosis in rat brain microvessels.
Kim SY; Choi ES; Lee HJ; Moon C; Kim E
Colloids Surf B Biointerfaces; 2015 Dec; 136():989-96. PubMed ID: 26562191
[TBL] [Abstract][Full Text] [Related]
34. Use of LDL receptor-targeting peptide vectors for
Molino Y; David M; Varini K; Jabès F; Gaudin N; Fortoul A; Bakloul K; Masse M; Bernard A; Drobecq L; Lécorché P; Temsamani J; Jacquot G; Khrestchatisky M
FASEB J; 2017 May; 31(5):1807-1827. PubMed ID: 28108572
[TBL] [Abstract][Full Text] [Related]
35. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier.
Stanimirovic DB; Sandhu JK; Costain WJ
BioDrugs; 2018 Dec; 32(6):547-559. PubMed ID: 30306341
[TBL] [Abstract][Full Text] [Related]
36. Targeting blood-brain-barrier transcytosis - perspectives for drug delivery.
Mäger I; Meyer AH; Li J; Lenter M; Hildebrandt T; Leparc G; Wood MJA
Neuropharmacology; 2017 Jul; 120():4-7. PubMed ID: 27561970
[TBL] [Abstract][Full Text] [Related]
37. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
[TBL] [Abstract][Full Text] [Related]
38. The blood-brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells.
Abulrob A; Sprong H; Van Bergen en Henegouwen P; Stanimirovic D
J Neurochem; 2005 Nov; 95(4):1201-14. PubMed ID: 16271053
[TBL] [Abstract][Full Text] [Related]
39. Antibody Neutralization of HIV-1 Crossing the Blood-Brain Barrier.
Lorin V; Danckaert A; Porrot F; Schwartz O; Afonso PV; Mouquet H
mBio; 2020 Oct; 11(5):. PubMed ID: 33082263
[TBL] [Abstract][Full Text] [Related]
40. Glycocalyx is critical for blood-brain barrier integrity by suppressing caveolin1-dependent endothelial transcytosis following ischemic stroke.
Zhu J; Li Z; Ji Z; Wu Y; He Y; Liu K; Chang Y; Peng Y; Lin Z; Wang S; Wang D; Huang K; Pan S
Brain Pathol; 2022 Jan; 32(1):e13006. PubMed ID: 34286899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
